Canine Parainfluenza
Disease Overview
Canine parainfluenza virus (CPIV) is a highly contagious respiratory virus and is one of the most common pathogens of infectious tracheobronchitis, also known as canine cough.3Although the respiratory signs may resemble those of canine influenza, they are unrelated viruses and require different vaccines for protection.
Merck Animal Health Solutions
For Canine Parainfluenza
A vaccine recommended for use in healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.
Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus, and canine coronavirus.
Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus and against leptospiral disease due to L. canicola or L. icterohaemorrhagiae.
Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine coronavirus, canine parainfluenza virus, and canine parvovirus and against leptospiral disease due to L. canicola or L. icterohaemorrhagiae.
Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus. Additionally, it is an aid in the prevention of disease, urinary shedding and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa.
An intranasal vaccine shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine parainfluenza virus and Bordetella bronchiseptica.
An intranasal vaccine shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica.
An intranasal vaccine shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica.
Transmission
CPIV is excreted from the respiratory tract of infected animals for up to 2 weeks after infection and is usually transmitted through the air.3 The virus spreads rapidly in kennels or shelters where large numbers of dogs are kept together.4
Clinical Signs 3,4
- Coughing (dry or moist)
- Low-grade fever
- Nasal discharge
- Lack of energy
- Loss of appetite
Risk Factors
- Dogs that come from shelters, rescue centers, breeding kennels, or pet stores
- Boarding at a kennel or doggie daycare
- Visiting groomers, dog parks, or engaging with other dogs on a daily basis
- Dogs that participate in events/competitions
References:
3. Ford R. Canine infectious tracheobronchitis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2006:55.
4. Buonavoglia C, Martella V. Canine respiratory viruses. Vet Res. 2007;38:355–373.